The Impact of the Severity of Preeclampsia on Maternal IGF-1 Serum Levels and Fetal Outcomes: A Case–Control Analysis
Medical Journal of Babylon · 2026-01 · 23 (1) · 723-730
DOI: 10.4103/mjbl.mjbl_882_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Journal of Babylon, online erschienen am 30.04.2026. Verfasst von Anfal Ali Hussein Al-Kaabi und 4 weiteren Autor:innen. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
The problem of pre-eclampsia (PE), a life-threatening pregnancy condition, remains poorly understood. Placental growth and fetal development are affected by the presence of insulin-like growth factor 1 (IGF-1).
Objectives
This case–control study aimed to determine the correlation between maternal IGF-1 levels, PE disease severity, and fetal health outcomes. Materials and Methods: This case–control study was conducted over 11 months at the Department of Obstetrics, Babylon Hospital for Maternity and Children. We included 120 pregnant women in their third trimester (28–39 weeks), categorized into three groups: control, moderate PE, and severe PE. Data on maternal age, parity, and obstetric history were collected. Blood pressure was measured using a sphygmomanometer, and urine samples were tested for proteinuria. Serum IGF-1 levels were assessed using an enzyme-linked immunosorbent assay. Doppler ultrasound measures were also utilized to evaluate flow velocity waveforms in the umbilical artery.
Results
Maternal IGF-1 levels were significantly lower in women with severe PE compared to those with moderate PE and the control group ( P < 0.001). The study found that 75% of neonates from mothers with severe PE were admitted to the neonatal intensive care unit, while only 30% from the moderate group required admission. Neonatal birth weights were significantly lower in both PE groups than in controls ( P < 0.001).
Conclusion
The present study suggests a strong relationship between the severity of PE syndrome and maternal IGF-1 levels. Lower IGF-1 levels may be linked to PE development and adverse fetal outcomes. These findings highlight the potential of IGF-1 as a biomarker for PE severity and as a target for future research aimed at improving pregnancy outcomes.
Zitieren
APA
Al-Kaabi, A. A. H., Jasim, S. D., Al-Rubaye, Z. J. M., Mohammad, H. Q., & Almusawi, A. A. H. (2026). The Impact of the Severity of Preeclampsia on Maternal IGF-1 Serum Levels and Fetal Outcomes: A Case–Control Analysis. Medical Journal of Babylon, 23(1), 723-730. https://doi.org/10.4103/mjbl.mjbl_882_24
Vancouver
Al-Kaabi AAH, Jasim SD, Al-Rubaye ZJM, Mohammad HQ, Almusawi AAH. The Impact of the Severity of Preeclampsia on Maternal IGF-1 Serum Levels and Fetal Outcomes: A Case–Control Analysis. Medical Journal of Babylon. 2026;23(1):723-730. doi:10.4103/mjbl.mjbl_882_24
BibTeX
@article{AlKaabi2026,
author = {Al-Kaabi, Anfal Ali Hussein and Jasim, Shaymaa Dakhil and Al-Rubaye, Zinah Jabbar Mohammed and Mohammad, Hasanain Qasim and Almusawi, Ali Abbas Hashim},
title = {The Impact of the Severity of Preeclampsia on Maternal IGF-1 Serum Levels and Fetal Outcomes: A Case–Control Analysis},
journal = {Medical Journal of Babylon},
year = {2026},
volume = {23},
number = {1},
pages = {723--730},
doi = {10.4103/mjbl.mjbl_882_24}
}
EUVIMED